'Antiretroviral treatment' diaporamas de présentation

HIV in People Who Use Drugs

HIV in People Who Use Drugs. Adeeba Kamarulzaman University of Malaya Kuala Lumpur, Malaysia. Outline. Global Burden of HIV due to illicit drug use The Global State of Harm Reduction Unmet needs and new challenges Women Adolescents MSM Prison and people who use drugs

681 views • 47 slides

Chapter 8 Children with HIV/AIDS

Chapter 8 Children with HIV/AIDS. Case study: Thomas.

416 views • 31 slides

The HIV and AIDS Pandemic in Africa and Canadian Response CHV 20

The HIV and AIDS Pandemic in Africa and Canadian Response CHV 20. What is a Non-Governmental Organization (NGO)?.

397 views • 29 slides

Chapter 8 Children with HIV/AIDS

Chapter 8 Children with HIV/AIDS. Case study: Thomas. Thomas, 8-month old boy was brought to hospital with history of fever for eight days. He had not been able to eat or drink anything for 2 days because of sores in his mouth. Stages in the management of a sick child (Ref. Chart 1, p. xxii).

253 views • 25 slides

Treatment of HIV Stops Transmission : Where DO We Go From Here? Cohen et al Lancet , Nov. 2013

Treatment of HIV Stops Transmission : Where DO We Go From Here? Cohen et al Lancet , Nov. 2013. Myron S. Cohen, MD Yergan-Bate Professor Medicine, Microbiology and Epidemiology Director, Institute for Global Health & Infectious Diseases. BACK TO BASICS How HIV Became Pandemic. Ro = bDC

296 views • 23 slides

Treatment of HIV Stops Transmission : Where DO We Go From Here? Cohen et al Lancet , Nov. 2013

Treatment of HIV Stops Transmission : Where DO We Go From Here? Cohen et al Lancet , Nov. 2013. Myron S. Cohen, MD Yergan-Bate Professor Medicine, Microbiology and Epidemiology Director, Institute for Global Health & Infectious Diseases. BACK TO BASICS How HIV Became Pandemic. Ro = bDC

338 views • 23 slides

Treatment of HIV Stops Transmission : Where DO We Go From Here? Cohen et al Lancet , Nov. 2013

Treatment of HIV Stops Transmission : Where DO We Go From Here? Cohen et al Lancet , Nov. 2013. Myron S. Cohen, MD Yergan-Bate Professor Medicine, Microbiology and Epidemiology Director, Institute for Global Health & Infectious Diseases. BACK TO BASICS How HIV Became Pandemic. Ro = bDC

239 views • 23 slides

Social Context of HIV/AIDS in Africa

271 views • 19 slides

Treat 3 million by 2005

Treat 3 million by 2005. What is "3 by 5" Target?. 38 million people living with HIV/AIDS worldwide 6 million people are in need of antiretroviral treatment (ART) 440,000 people have access to treatment 3 million people die every year because they can not get the treatment

276 views • 16 slides

Background

Barriers to HIV care and Antiretroviral Treatment (ART) among HIV-infected Crack Users in the United States. Christine Bell 1 Gabriel Cardenas 2 Tanisha Sullivan 1 Tamy Kuper 2 Lauren Gooden 2 Jessica Kaplan 1 Elizabeth Scharf 1 Allan Rodriguez 2 Carlos del Rio 1 Lisa Metsch 2

260 views • 13 slides

mHealth Working Group

mHealth Working Group. April 20, 2011 Held at FHI. Principles of the Working Group. Frame mHealth in global health strategies Apply public health standards & practices Promote appropriate, evidence-based, scalable and interoperable approaches in resource-poor settings

210 views • 9 slides

KATINKA DE WET & EDWIN WOUTERS UNIVERSITY OF THE FREE STATE, SOUTH AFRICA &

A LONGITUDINAL IN-DEPTH STUDY OF GENDER-SPECIFIC EXPERIENCES IN ANTIRETROVIRAL TREATMENT IN PATIENTS IN SOUTH AFRICA. KATINKA DE WET & EDWIN WOUTERS UNIVERSITY OF THE FREE STATE, SOUTH AFRICA & UNIVERSITY OF ANTWERP, BELGIUM 19 TH INTERNATIONAL AIDS CONFERENCE WASHINGTON, USA.

192 views • 9 slides

Laboratory Diagnosis AND Prevention

210 views • 7 slides

MDG 6: Combat HIV/AIDS and other diseases

173 views • 6 slides

Travel time and distance are barriers to care for HIV-infected children in resource-poor settings

169 views • 4 slides

C5 Critical HIV Prevention

C5 Critical HIV Prevention . 1. Patient is exposed to HIV. 2. Patient Contacts the Care Centre. 3. Verification on Programme. 4. HIV prevention treatment dispatched by ER24 to arrive at the Patient within the first 5 hours after exposure. 5. Advised to nearest facility or

149 views • 2 slides